IP Library Granted Patent US 10,087,473
Granted Patent B2
US 10,087,473 · App. 15/526,031 · Granted Oct 2, 2018

Method for manufacturing cis-5-hydroxy-L-pipecolic acid

Inventors: Ryoma Miyake (Kanagawa, JP); Yasumasa Dekishima (Kanagawa, JP)
Assignee: API CORPORATION
C12P17/12C12N9/0071C12Y114/11
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,087,473
App. No.
15/526,031
Granted
Oct 2, 2018
Kind
B2
Abstract

A method for producing cis-5-hydroxy-L-pipecolic acid, the method comprising allowing a 2-oxoglutarate-dependent L-pipecolic acid hydroxylase to act on L-pipecolic acid to generate cis-5-hydroxy-L-pipecolic acid, wherein the 2-oxoglutarate-dependent L-pipecolic acid hydroxylase comprises the polypeptide (A), (B) or (C) below: (A) a polypeptide comprising the amino acid sequence represented by SEQ ID NO: 4 or 11; (B) a polypeptide comprising the amino acid sequence represented by SEQ ID NO: 4 or 11 except that one or several amino acids are deleted, substituted, and/or added, which polypeptide has 2-oxoglutarate-dependent L-pipecolic acid hydroxylase activity; or (C) a polypeptide comprising an amino acid sequence with an identity of not less than 60% to the amino acid sequence represented by SEQ ID NO: 4 or 11, which polypeptide has 2-oxoglutarate-dependent L-pipecolic acid hydroxylase activity.

Claims (13)

1. A method for producing cis-5-hydroxy-L-pipecolic acid, the method comprising allowing a 2-oxoglutarate-dependent L-pipecolic acid hydroxylase, a microorganism or cell that produces the enzyme, a processed product of the microorganism or cell having the enzyme, and/or a culture liquid comprising the enzyme and obtained by culturing the microorganism or cell, to act on L-pipecolic acid to generate cis-5-hydroxy-L-pipecolic acid,

wherein the 2-oxoglutarate-dependent L-pipecolic acid hydroxylase comprises:

(A) a polypeptide comprising the amino acid sequence of SEQ ID NO: 4 or 11;

(B) a polypeptide comprising the amino acid sequence of SEQ ID NO: 4 or 11 except that 1 to 10 amino acids are deleted, substituted, and/or added, wherein said polypeptide has 2-oxoglutarate-dependent L-pipecolic acid hydroxylase activity; or

(C) a polypeptide comprising an amino acid sequence with an identity of not less than 90% to the amino acid sequence of SEQ ID NO: 4 or 11, wherein said polypeptide has 2-oxoglutarate-dependent L-pipecolic acid hydroxylase activity.

2. The method for producing cis-5-hydroxy-L-pipecolic acid according to claim 1 , wherein DNA encoding the 2-oxoglutarate-dependent L-pipecolic acid hydroxylase comprises:

(a) DNA comprising the nucleotide sequence of SEQ ID NO: 1 or 10;

(b) DNA comprising the nucleotide sequence of SEQ ID NO: 1 or 10 except that 1 to 30 nucleotides are substituted, deleted, and/or added, wherein said DNA encodes a polypeptide having 2-oxoglutarate-dependent L-pipecolic acid hydroxylase activity; or

(c) DNA which hybridizes with the full-length complementary strand of the polynucleotide of SEQ ID NO: 1 or 10 under stringent conditions, wherein the conditions comprise a hybridization at 65° C. in the presence of 0.7 mol/L to 1.0 mol/L sodium chloride aqueous solution and a washing under a temperature condition of 65° C. by using one solution with an SSC concentration ranging from 0.1 to 2×SSC (the composition of 1×SSC: 150 mmol/L sodium chloride aqueous solution, 15 mmol/L sodium citrate aqueous solution), wherein said DNA encodes a polypeptide having 2-oxoglutarate-dependent L-pipecolic acid hydroxylase activity.

3. The method for producing cis-5-hydroxy-L-pipecolic acid according to claim 1 , wherein the 2-oxoglutarate-dependent L-pipecolic acid hydroxylase, the microorganism or cell that produces the enzyme, the processed product of the microorganism or cell having the enzyme, and/or the culture liquid comprising the enzyme and obtained by culturing the microorganism or cell is/are allowed to act on said L-pipecolic acid in the presence of 2-oxoglutaric acid and a ferrous ion.

4. The method for producing cis-5-hydroxy-L-pipecolic acid according to claim 2 , wherein the 2-oxoglutarate-dependent L-pipecolic acid hydroxylase, the microorganism or cell that produces the enzyme, the processed product of the microorganism or cell having the enzyme, and/or the culture liquid comprising the enzyme and obtained by culturing the microorganism or cell is/are allowed to act on said L-pipecolic acid in the presence of 2-oxoglutaric acid and a ferrous ion.

5. A 2-oxoglutarate-dependent L-pipecolic acid hydroxylase protein having an activity to act on L-pipecolic acid to generate cis-5-hydroxy-L-pipecolic acid, wherein said 2-oxoglutarate-dependent L-pipecolic acid hydroxylase protein comprises:

a polypeptide comprising the amino acid sequence of SEQ ID NO: 4 or 11 except that 1-10 amino acids are substituted and/or added, wherein said polypeptide has 2-oxoglutarate-dependent L-pipecolic acid hydroxylase activity.

Assignments (3)
CHANGE OF ADDRESS Recorded Aug 21, 2025
From: API CORPORATION
To: API CORPORATION
Reel/Frame 072498/0511 →
MERGER Recorded Aug 21, 2025
From: API CORPORATION
To: UBE CORPORATION
Reel/Frame 072554/0211 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2017
From: MIYAKE, RYOMA; DEKISHIMA, YASUMASA
To: API CORPORATION
Reel/Frame 042338/0903 →
Priority Claims (1)
JP 2014-229685 · Nov 12, 2014 · national
Continuity (1)
Related Publication 20170306367A1 · Oct 26, 2017